Shyam Srivats

Shyam Srivats

Genentech, Inc - South San Francisco / United States
Engineering & Technology / Nanoscience and Nanotechnology
AD Scientific Index ID: 4484716
-
person_outline Shyam Srivats's MOST POPULAR ARTICLES
1-) Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancerNS Patil, BY Nabet, S Müller, H Koeppen, W Zou, J Giltnane, A Au-Yeung, ...Cancer Cell 40 (3), 289-300. e4, 20221112022
2-) Sigma1 receptors inhibit store-operated Ca2+ entry by attenuating coupling of STIM1 to Orai1S Srivats, D Balasuriya, M Pasche, G Vistal, JM Edwardson, CW Taylor, ...Journal of Cell Biology 213 (1), 65-79, 2016942016
3-) Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancerQ Wang, H Alshaker, T Böhler, S Srivats, Y Chao, C Cooper, D PchejetskiScientific reports 7 (1), 5901, 2017612017
4-) Therapeutic potential of targeting SK1 in human cancersH Alshaker, L Sauer, D Monteil, S Ottaviani, S Srivats, T Böhler, ...Advances in cancer research 117, 143-200, 2013622013
5-) Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacyA Paraskar, S Soni, S Basu, CJ Amarasiriwardena, N Lupoli, S Srivats, ...Nanotechnology 22 (26), 265101, 2011392011